Actively Recruiting
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS) - A Prospective Study
Led by Synchrony-Medical, Ltd · Updated on 2026-04-13
200
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate how adults with bronchiectasis use the LibAirty132; Airway Clearance System at home and how it affects their lung symptoms and healthcare needs. The study focuses on measuring how often participants experience flare-ups of their lung condition, called pulmonary exacerbations, while using the device over a 12-month period. The study is observational and collects real-world data without changing participants' standard treatments. Participants have been prescribed the LibAirty132; system by their doctors as part of their usual care and continue using it at home as directed. The study does not provide the device nor assign its use. Over the 12 months, data will be gathered during up to four regular clinic visits, including questionnaires about symptoms and device satisfaction, medical record reviews, and device usage logs to track adherence. During these visits, researchers will also monitor hospital stays, emergency room visits, antibiotic use, lung function tests, quality of life changes, and healthcare resource use related to bronchiectasis. Participants will maintain their normal clinic appointments and treatment plans throughout the study. The total participation time is 12 months from when individuals begin using the LibAirty132; system at home.
CONDITIONS
Brief Title
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a radiological diagnosis of bronchiectasis based on a high resolution chest CT scan
- Have bronchiectasis with either a daily productive cough or documentation of two or more pulmonary exacerbations requiring antibiotics in the past 12 months
- Be 21 years of age or older
- Be prescribed and currently use the LibAirty system at home
- Be on a standard care plan with at least one doctor visit every 6 months
- Have had no changes in bronchiectasis treatment in the 2 months before enrollment
- Provide signed informed consent
You will not qualify if you...
- Unable to use the LibAirty system independently as directed
- Any condition that may affect safety or study results according to the principal investigator
- Pregnancy or planning pregnancy during the 12-month study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 months
Participants who use the LibAirty airway clearance system as part of their routine care are observed to evaluate clinical outcomes, adherence, and user experience over time.
Up to 4 visits during routine clinical care
Trial Site Locations
Total: 3 locations
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
Actively Recruiting
2
Emory University School Of Medicine
Atlanta, Georgia, United States, 30342
Actively Recruiting
3
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here